PROVEN PROCESS

Combining the best practices of world-class organizations with a nimble “portfolio approach” to cutting-edge science, we launch visionary companies by leveraging our clinical development, regulatory, manufacturing and commercialization expertise.

PROVEN PROCESS

Combining the best practices of world-class organizations with a nimble “portfolio approach” to cutting-edge science, we launch visionary companies by leveraging our clinical development, regulatory, manufacturing and commercialization expertise.

Create

We identify a large, unmet need and utilize internal and external networks of scientists, labs, and institutions to assess the viability of the science.

Create

We identify a large, unmet need and utilize internal and external networks of scientists, labs, and institutions to assess the viability of the science.

Invest

Along with our partners, we invest capital to advance science, having invested approximately $1 billion in our portfolio companies since 2017 and expect ongoing investments of up to $500 million annually.

Invest

Along with our partners, we invest capital to advance science, having invested approximately $1 billion in our portfolio companies since 2017 and expect ongoing investments of up to $500 million annually.

Build

We build new companies, leveraging turn-key clinical, regulatory, financial, and operational expertise until they are self-sufficient, and exit to strategic acquirers or IPO.

Build

We build new companies, leveraging turn-key clinical, regulatory, financial, and operational expertise until they are self-sufficient, and exit to strategic acquirers or IPO.